HUMAN:APOA2

From GONUTS

Jump to: navigation, search

Species (Taxon ID)	Homo sapiens (Human). (taxon:9606)
Gene Name(s)	APOA2
Protein Name(s)	Apolipoprotein A-II Apo-AII ApoA-II Apolipoprotein A2 Apolipoprotein A-II(1-76)
External Links
UniProt Identifier	APOA2_HUMAN
UniProt Accessions	P02652, B2R524,
EMBL	X04898, X00955, X02905, X02619, M29882, AY100524, AK312034, BT006786, AL590714, BC005282,
PIR	A93586,
RefSeq	NP_001634.1,
PDB	1L6L, 2OU1,
Ensembl	ENST00000367990,
Pfam	PF04711,

Annotations

Qualifier	GO ID	GO term name	Reference	Evidence Code	with/from	Aspect	Notes	Status
	GO:0042627	chylomicron		IDA: Inferred from Direct Assay		C	Source: UniProtKB
	GO:0005788	endoplasmic reticulum lumen		EXP: Inferred from Experiment		C	Source: Reactome
	GO:0034364	high-density lipoprotein particle		IEA		C	Source: UniProtKB-KW
	GO:0034361	very-low-density lipoprotein particle		IDA: Inferred from Direct Assay		C	Source: UniProtKB
	GO:0034190	apolipoprotein receptor binding		IPI: Inferred from Physical Interaction		F	Source: UniProtKB
	GO:0015485	cholesterol binding		IDA: Inferred from Direct Assay		F	Source: UniProtKB
	GO:0055102	lipase inhibitor activity		IDA: Inferred from Direct Assay		F	Source: UniProtKB
	GO:0005319	lipid transporter activity		IDA: Inferred from Direct Assay		F	Source: UniProtKB
	GO:0031210	phosphatidylcholine binding		IDA: Inferred from Direct Assay		F	Source: UniProtKB
	GO:0060228	phosphatidylcholine-sterol O-acyltransferas...		IDA: Inferred from Direct Assay		F	Source: UniProtKB
	GO:0046982	protein heterodimerization activity		IPI: Inferred from Physical Interaction		F	Source: UniProtKB
	GO:0042803	protein homodimerization activity		IDA: Inferred from Direct Assay		F	Source: UniProtKB
	GO:0046340	diacylglycerol catabolic process		IDA: Inferred from Direct Assay		P	Source: UniProtKB	required field missing
	GO:0033344	cholesterol efflux		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0042632	cholesterol homeostasis		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0034380	high-density lipoprotein particle assembly		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0042157	lipoprotein metabolic process		IEA		P	Source: InterPro
	GO:0034381	lipoprotein particle clearance		TAS: Traceable Author Statement		P	Source: UniProtKB
	GO:0032375	negative regulation of cholesterol transport		IMP: Inferred from Mutant Phenotype		P	Source: UniProtKB
	GO:0060192	negative regulation of lipase activity		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0050995	negative regulation of lipid catabolic process		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0006656	phosphatidylcholine biosynthetic process		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0033700	phospholipid efflux		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0032375	negative regulation of cholesterol transport		IDA: Inferred from Direct Assay		P		required field missing
	GO:0009749	response to glucose stimulus		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0043691	reverse cholesterol transport		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0034375	high-density lipoprotein particle remodeling		IDA: Inferred from Direct Assay		P		required field missing
	GO:0006641	triglyceride metabolic process		TAS: Traceable Author Statement		P	Source: UniProtKB
	GO:0034384	high-density lipoprotein particle clearance		IDA: Inferred from Direct Assay		P		required field missing
	GO:0034370	triglyceride-rich lipoprotein particle remo...		IDA: Inferred from Direct Assay		P	Source: UniProtKB
	GO:0010873	positive regulation of cholesterol esterification		IDA: Inferred from Direct Assay		P		required field missing
	GO:0009395	phospholipid catabolic process		IDA: Inferred from Direct Assay		P		required field missing
	GO:0010903	negative regulation of very-low-density lipoprotein particle remodeling		IDA: Inferred from Direct Assay		P		required field missing
	GO:0032410	negative regulation of transporter activity		IDA: Inferred from Direct Assay		P		required field missing
	GO:0034374	low-density lipoprotein particle remodeling		IDA: Inferred from Direct Assay		P		required field missing
	GO:0050996	positive regulation of lipid catabolic process		IDA: Inferred from Direct Assay		P		required field missing
	GO:0002526	acute inflammatory response	GO_REF:0000019	IEA: Inferred from Electronic Annotation	Ensembl:ENSRNOP00000004662	P
	GO:0002740	negative regulation of cytokine secretion involved in immune response	PMID:12458630^[1]	IDA: Inferred from Direct Assay		P
	GO:0005319	lipid transporter activity	PMID:1606170^[2]	IDA: Inferred from Direct Assay		F
	GO:0005515	protein binding	PMID:11991719^[3]	IPI: Inferred from Physical Interaction	UniProtKB:Q8NCW5	F
	GO:0005543	phospholipid binding	PMID:218942^[4]	IDA: Inferred from Direct Assay		F
	GO:0005576	extracellular region	GO_REF:0000002	IEA: Inferred from Electronic Annotation	InterPro:IPR006801	C
	GO:0005576	extracellular region	GO_REF:0000004	IEA: Inferred from Electronic Annotation	SP_KW:KW-0964	C
	GO:0005576	extracellular region	GO_REF:0000023	IEA: Inferred from Electronic Annotation	SP_SL:SL-0243	C
	GO:0005576	extracellular region	PMID:14718574^[5]	NAS: Non-traceable Author Statement		C
	GO:0005576	extracellular region	Reactome:REACT_22360	TAS: Traceable Author Statement		C
	GO:0005576	extracellular region	Reactome:REACT_6727	TAS: Traceable Author Statement		C
	GO:0005576	extracellular region	Reactome:REACT_6734	TAS: Traceable Author Statement		C
	GO:0005576	extracellular region	Reactome:REACT_6813	TAS: Traceable Author Statement		C
	GO:0005576	extracellular region	Reactome:REACT_6852	TAS: Traceable Author Statement		C
	GO:0005788	endoplasmic reticulum lumen	Reactome:REACT_6813	TAS: Traceable Author Statement		C
	GO:0005788	endoplasmic reticulum lumen	Reactome:REACT_6915	TAS: Traceable Author Statement		C
	GO:0006457	protein folding	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0006629	lipid metabolic process	Reactome:REACT_602	TAS: Traceable Author Statement		P
	GO:0006641	triglyceride metabolic process	PMID:11551871^[7]	TAS: Traceable Author Statement		P
	GO:0006656	phosphatidylcholine biosynthetic process	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0006810	transport	GO_REF:0000004	IEA: Inferred from Electronic Annotation	SP_KW:KW-0813	P
	GO:0006869	lipid transport	GO_REF:0000002	IEA: Inferred from Electronic Annotation	InterPro:IPR006801	P
	GO:0006869	lipid transport	GO_REF:0000004	IEA: Inferred from Electronic Annotation	SP_KW:KW-0445	P
	GO:0008289	lipid binding	GO_REF:0000002	IEA: Inferred from Electronic Annotation	InterPro:IPR006801	F
	GO:0008289	lipid binding	PMID:14967812^[6]	IDA: Inferred from Direct Assay		F
	GO:0009395	phospholipid catabolic process	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0009749	response to glucose stimulus	PMID:14988251^[8]	IDA: Inferred from Direct Assay		P
	GO:0010873	positive regulation of cholesterol esterification	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0010903	negative regulation of very-low-density lipoprotein particle remodeling	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0015485	cholesterol binding	PMID:218942^[4]	IDA: Inferred from Direct Assay		F
	GO:0017127	cholesterol transporter activity	GO_REF:0000019	IEA: Inferred from Electronic Annotation	Ensembl:ENSRNOP00000004662	F
	GO:0030301	cholesterol transport	GO_REF:0000019	IEA: Inferred from Electronic Annotation	Ensembl:ENSRNOP00000004662	P
	GO:0031100	organ regeneration	GO_REF:0000019	IEA: Inferred from Electronic Annotation	Ensembl:ENSRNOP00000004662	P
	GO:0031210	phosphatidylcholine binding	PMID:17264082^[9]	IDA: Inferred from Direct Assay		F
	GO:0031647	regulation of protein stability	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0032375	negative regulation of cholesterol transport	PMID:8636092^[10]	IMP: Inferred from Mutant Phenotype		P
	GO:0033344	cholesterol efflux	PMID:11162594^[11]	IDA: Inferred from Direct Assay		P
	GO:0033700	phospholipid efflux	PMID:11162594^[11]	IDA: Inferred from Direct Assay		P
	GO:0034190	apolipoprotein receptor binding	PMID:11162594^[11]	IPI: Inferred from Physical Interaction	UniProtKB:O95477	F
	GO:0034361	very-low-density lipoprotein particle	PMID:8245722^[12]	IDA: Inferred from Direct Assay		C
	GO:0034364	high-density lipoprotein particle	GO_REF:0000004	IEA: Inferred from Electronic Annotation	SP_KW:KW-0345	C
	GO:0034364	high-density lipoprotein particle	PMID:17264082^[9]	IDA: Inferred from Direct Assay		C
	GO:0034364	high-density lipoprotein particle	PMID:210174^[13]	IDA: Inferred from Direct Assay		C
	GO:0034364	high-density lipoprotein particle	PMID:3104518^[14]	IDA: Inferred from Direct Assay		C
	GO:0034366	spherical high-density lipoprotein particle	PMID:16682745^[15]	IDA: Inferred from Direct Assay		C
	GO:0034370	triglyceride-rich lipoprotein particle remodeling	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0034374	low-density lipoprotein particle remodeling	PMID:8106353^[16]	IDA: Inferred from Direct Assay		P
	GO:0034375	high-density lipoprotein particle remodeling	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0034375	high-density lipoprotein particle remodeling	PMID:8106353^[16]	IDA: Inferred from Direct Assay		P
	GO:0034380	high-density lipoprotein particle assembly	PMID:218942^[4]	IDA: Inferred from Direct Assay		P
	GO:0034384	high-density lipoprotein particle clearance	PMID:10764676^[17]	IDA: Inferred from Direct Assay		P
	GO:0042157	lipoprotein metabolic process	GO_REF:0000002	IEA: Inferred from Electronic Annotation	InterPro:IPR006801	P
	GO:0042157	lipoprotein metabolic process	Reactome:REACT_6823	TAS: Traceable Author Statement		P
	GO:0042157	lipoprotein metabolic process	Reactome:REACT_6841	TAS: Traceable Author Statement		P
	GO:0042493	response to drug	GO_REF:0000019	IEA: Inferred from Electronic Annotation	Ensembl:ENSRNOP00000004662	P
	GO:0042627	chylomicron	PMID:8245722^[12]	IDA: Inferred from Direct Assay		C
	GO:0042632	cholesterol homeostasis	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0042803	protein homodimerization activity	PMID:17264082^[9]	IDA: Inferred from Direct Assay		F
	GO:0043627	response to estrogen stimulus	GO_REF:0000019	IEA: Inferred from Electronic Annotation	Ensembl:ENSRNOP00000004662	P
	GO:0043691	reverse cholesterol transport	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0044255	cellular lipid metabolic process	Reactome:REACT_22279	TAS: Traceable Author Statement		P
	GO:0044419	interspecies interaction between organisms	GO_REF:0000004	IEA: Inferred from Electronic Annotation	SP_KW:KW-0945	P
	GO:0045416	positive regulation of interleukin-8 biosynthetic process	PMID:11591715^[18]	IDA: Inferred from Direct Assay		P
	GO:0046340	diacylglycerol catabolic process	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0046982	protein heterodimerization activity	PMID:7918467^[19]	IPI: Inferred from Physical Interaction	UniProtKB:P05090	F
	GO:0046982	protein heterodimerization activity	PMID:8245722^[12]	IPI: Inferred from Physical Interaction	UniProtKB:P02649	F
	GO:0046982	protein heterodimerization activity	PMID:8245722^[12]	IPI: Inferred from Physical Interaction	UniProtKB:P04114	F
	GO:0050995	negative regulation of lipid catabolic process	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0050996	positive regulation of lipid catabolic process	PMID:8640403^[20]	IDA: Inferred from Direct Assay		P
	GO:0051384	response to glucocorticoid stimulus	GO_REF:0000019	IEA: Inferred from Electronic Annotation	Ensembl:ENSRNOP00000004662	P
	GO:0055102	lipase inhibitor activity	PMID:14967812^[6]	IDA: Inferred from Direct Assay		F
	GO:0060192	negative regulation of lipase activity	PMID:14967812^[6]	IDA: Inferred from Direct Assay		P
	GO:0060228	phosphatidylcholine-sterol O-acyltransferase activator activity	PMID:14967812^[6]	IDA: Inferred from Direct Assay		F
	GO:0060621	negative regulation of cholesterol import	PMID:10764676^[17]	IDA: Inferred from Direct Assay		P
	GO:0060695	negative regulation of cholesterol transporter activity	PMID:8106353^[16]	IDA: Inferred from Direct Assay		P
	GO:0070653	high-density lipoprotein particle receptor binding	PMID:10764676^[17]	IPI: Inferred from Physical Interaction	UniProtKB:Q8WTV0	F
contributes_to	GO:0017127	cholesterol transporter activity	PMID:9651324^[21]	IDA: Inferred from Direct Assay		F
edit table

Notes

References

See Help:References for how to manage references in GONUTS.

↑ Furlaneto CJ et al. (2002) Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids 37: 925-8 PubMed GONUTS page
↑ Bekaert ED et al. (1992) Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma. Biochim Biophys Acta 1126: 105-13 PubMed GONUTS page
↑ Ritter M et al. (2002) Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. Genomics 79: 693-702 PubMed GONUTS page
↑ ^4.0 ^4.1 ^4.2 Ritter MC & Scanu AM (1979) Apolipoprotein A-II and structure of human serum high density lipoproteins. An approach by reassembly techniques. J Biol Chem 254: 2517-25 PubMed GONUTS page
↑ Anderson NL et al. (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3: 311-26 PubMed GONUTS page
↑ ^6.00 ^6.01 ^6.02 ^6.03 ^6.04 ^6.05 ^6.06 ^6.07 ^6.08 ^6.09 ^6.10 ^6.11 ^6.12 ^6.13 ^6.14 ^6.15 Boucher J et al. (2004) Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J Lipid Res 45: 849-58 PubMed GONUTS page
↑ van 't Hooft FM et al. (2001) Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 104: 1223-8 PubMed GONUTS page
↑ Sauvaget D et al. (2004) In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose. Diabetes 53: 672-8 PubMed GONUTS page
↑ ^9.0 ^9.1 ^9.2 Silva RA et al. (2007) The structure of apolipoprotein A-II in discoidal high density lipoproteins. J Biol Chem 282: 9713-21 PubMed GONUTS page
↑ Marzal-Casacuberta A et al. (1996) Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II. J Biol Chem 271: 6720-8 PubMed GONUTS page
↑ ^11.0 ^11.1 ^11.2 Remaley AT et al. (2001) Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 280: 818-23 PubMed GONUTS page
↑ ^12.0 ^12.1 ^12.2 ^12.3 Connelly PW et al. (1993) Identification of disulfide-linked apolipoprotein species in human lipoproteins. J Lipid Res 34: 1717-27 PubMed GONUTS page
↑ Weisgraber KH & Mahley RW (1978) Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 253: 6281-8 PubMed GONUTS page
↑ Cheung MC et al. (1986) Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J Lipid Res 27: 1135-44 PubMed GONUTS page
↑ Christoffersen C et al. (2006) Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res 47: 1833-43 PubMed GONUTS page
↑ ^16.0 ^16.1 ^16.2 Lagrost L et al. (1994) Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII. J Biol Chem 269: 3189-97 PubMed GONUTS page
↑ ^17.0 ^17.1 ^17.2 Pilon A et al. (2000) Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake. Arterioscler Thromb Vasc Biol 20: 1074-81 PubMed GONUTS page
↑ Klezovitch O et al. (2001) Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain. J Biol Chem 276: 46864-9 PubMed GONUTS page
↑ Yang CY et al. (1994) Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links. Biochemistry 33: 12451-5 PubMed GONUTS page
↑ Mowri HO et al. (1996) Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Arterioscler Thromb Vasc Biol 16: 755-62 PubMed GONUTS page
↑ Wang WQ et al. (1998) Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem 273: 17391-8 PubMed GONUTS page

[PMID:12458630-0] Furlaneto CJ et al. (2002) Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids 37: 925-8 PubMed GONUTS page

[PMID:1606170-1] Bekaert ED et al. (1992) Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma. Biochim Biophys Acta 1126: 105-13 PubMed GONUTS page

[PMID:11991719-2] Ritter M et al. (2002) Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. Genomics 79: 693-702 PubMed GONUTS page

[PMID:218942-3] 4.0 ^4.1 ^4.2 Ritter MC & Scanu AM (1979) Apolipoprotein A-II and structure of human serum high density lipoproteins. An approach by reassembly techniques. J Biol Chem 254: 2517-25 PubMed GONUTS page

[PMID:14718574-4] Anderson NL et al. (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3: 311-26 PubMed GONUTS page

[PMID:14967812-5] 6.00 ^6.01 ^6.02 ^6.03 ^6.04 ^6.05 ^6.06 ^6.07 ^6.08 ^6.09 ^6.10 ^6.11 ^6.12 ^6.13 ^6.14 ^6.15 Boucher J et al. (2004) Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J Lipid Res 45: 849-58 PubMed GONUTS page

[PMID:11551871-6] van 't Hooft FM et al. (2001) Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 104: 1223-8 PubMed GONUTS page

[PMID:14988251-7] Sauvaget D et al. (2004) In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose. Diabetes 53: 672-8 PubMed GONUTS page

[PMID:17264082-8] 9.0 ^9.1 ^9.2 Silva RA et al. (2007) The structure of apolipoprotein A-II in discoidal high density lipoproteins. J Biol Chem 282: 9713-21 PubMed GONUTS page

[PMID:8636092-9] Marzal-Casacuberta A et al. (1996) Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II. J Biol Chem 271: 6720-8 PubMed GONUTS page

[PMID:11162594-10] 11.0 ^11.1 ^11.2 Remaley AT et al. (2001) Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 280: 818-23 PubMed GONUTS page

[PMID:8245722-11] 12.0 ^12.1 ^12.2 ^12.3 Connelly PW et al. (1993) Identification of disulfide-linked apolipoprotein species in human lipoproteins. J Lipid Res 34: 1717-27 PubMed GONUTS page

[PMID:210174-12] Weisgraber KH & Mahley RW (1978) Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 253: 6281-8 PubMed GONUTS page

[PMID:3104518-13] Cheung MC et al. (1986) Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J Lipid Res 27: 1135-44 PubMed GONUTS page

[PMID:16682745-14] Christoffersen C et al. (2006) Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res 47: 1833-43 PubMed GONUTS page

[PMID:8106353-15] 16.0 ^16.1 ^16.2 Lagrost L et al. (1994) Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII. J Biol Chem 269: 3189-97 PubMed GONUTS page

[PMID:10764676-16] 17.0 ^17.1 ^17.2 Pilon A et al. (2000) Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake. Arterioscler Thromb Vasc Biol 20: 1074-81 PubMed GONUTS page

[PMID:11591715-17] Klezovitch O et al. (2001) Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain. J Biol Chem 276: 46864-9 PubMed GONUTS page

[PMID:7918467-18] Yang CY et al. (1994) Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links. Biochemistry 33: 12451-5 PubMed GONUTS page

[PMID:8640403-19] Mowri HO et al. (1996) Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Arterioscler Thromb Vasc Biol 16: 755-62 PubMed GONUTS page

[PMID:9651324-20] Wang WQ et al. (1998) Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem 273: 17391-8 PubMed GONUTS page

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

HUMAN:APOA2

Contents

Annotations

Notes

References

a

c

d

e

h

h cont.

i

l

m

n

o

p

p cont.

r

s

t

v

Personal tools

Namespaces

Variants

Views

Actions

Search

Navigation

Cacao

Journal Clubs

page contributors

Toolbox